Microtubules are structural polymers inside of cells that are subject to posttranslational modifications. These posttranslational modifications create functionally distinct subsets of microtubule networks in the cell, and acetylation is the only modification that takes place in the hollow lumen of the microtubule. Although it is known that the α-tubulin acetyltransferase (αTAT1) is the primary enzyme responsible for microtubule acetylation, the mechanism for how αTAT1 enters the microtubule lumen to access its acetylation sites is not well understood. By performing biochemical assays, fluorescence and electron microscopy experiments, and computational simulations, we found that αTAT1 enters the microtubule lumen through the microtubule ends, and through bends or breaks in the lattice. Thus, microtubule structure is an important determinant in the acetylation process. In addition, once αTAT1 enters the microtubule lumen, the mobility of αTAT1 within the lumen is controlled by the affinity of αTAT1 for its acetylation sites, due to the rapid rebinding of αTAT1 onto highly concentrated α-tubulin acetylation sites. These results have important implications for how acetylation could gradually accumulate on stable subsets of microtubules inside of the cell. microtubule | acetylation | biophysics | microscopy | modeling
Microtubules are structural polymers inside of cells that are subject to posttranslational modifications. These posttranslational modifications create functionally distinct subsets of microtubule networks in the cell, and acetylation is the only modification that takes place in the hollow lumen of the microtubule. Although it is known that the α-tubulin acetyltransferase (αTAT1) is the primary enzyme responsible for microtubule acetylation, the mechanism for how αTAT1 enters the microtubule lumen to access its acetylation sites is not well understood. By performing biochemical assays, fluorescence and electron microscopy experiments, and computational simulations, we found that αTAT1 enters the microtubule lumen through the microtubule ends, and through bends or breaks in the lattice. Thus, microtubule structure is an important determinant in the acetylation process. In addition, once αTAT1 enters the microtubule lumen, the mobility of αTAT1 within the lumen is controlled by the affinity of αTAT1 for its acetylation sites, due to the rapid rebinding of αTAT1 onto highly concentrated α-tubulin acetylation sites. These results have important implications for how acetylation could gradually accumulate on stable subsets of microtubules inside of the cell. microtubule | acetylation | biophysics | microscopy | modeling M icrotubules are dynamic structural polymers that participate in cell and organelle morphology and motility, intracellular transport, signaling, and chromosome movement during mitosis. Despite these various roles, microtubule structure is highly conserved: microtubules across a wide range of organisms are hollow tube structures that are made up of αand β-tubulin heterodimers stacked end-to-end into protofilaments. For microtubules to perform such a wide range of tasks, the cell uses a variety of posttranslational modifications to fine-tune their function (1, 2) . Unlike the other known microtubule posttranslational modifications, the enzyme responsible for microtubule acetylation must access the α-tubulin Lysine 40 (Lys40) site inside the hollow portion of the microtubule, known as the lumen, to acetylate microtubules (3, 4) . Because of this unique localization to the lumen, the functional consequences of microtubule acetylation were initially puzzling to the field. However, recent functional studies have revealed effects of microtubule acetylation on cell signaling (5) , cell cycle progression (6) , and breast cancer cell migration (7) . In humans, microtubule acetylation may be important for intracellular cargo transport in neurons and neuronal maintenance in neurodegenerative disease contexts, including Alzheimer's (8), Parkinson's (9, 10) , and Huntington's (11) diseases.
The primary enzyme that is responsible for α-tubulin Lys40 acetylation in mammals, nematodes, and protozoa has been identified as α-tubulin acetyltransferase 1 (αTAT1), which was first found in Tetrahymena and Caenorhabditis elegans (12) (13) (14) . However, despite identification of the enzyme and its substrate, the mechanism for how αTAT1 enters the microtubule lumen to access its acetylation sites is yet to be fully understood. There are several potential mechanisms for how αTAT1 may access the acetylation site on the inside of the microtubule lumen: by copolymerization with tubulin at growing microtubule plus-ends (15) , by transient openings in the lattice during microtubule breathing (13, 16, 17) , or by microtubule end-entry (12, 18) . Copolymerization is not likely to be the primary mechanism for αTAT1 access, because stable microtubules are acetylated, and because αTAT1 is more active on polymerized microtubules than on free tubulin dimers (12, 13, (19) (20) (21) (22) (23) (24) (25) . Conversely, the other modes of access are possible (12, 13, 18) . Distinguishing among these possibilities is important for developing a mechanistic understanding to explain how αTAT1 could access its acetylation sites to facilitate microtubule acetylation.
In this work, we found that αTAT1 enters the microtubule lumen from the microtubule ends, and through breaks and bends in the lattice. Further, recent work suggested that αTAT1 was able to diffuse efficiently within the microtubule lumen, and thus acetylate microtubules without a preference for microtubule ends (18) . However, our results support a model in which the mobility of αTAT1 within the lumen is controlled by the affinity of αTAT1 for its acetylation sites, which are highly concentrated inside of the microtubule lumen, and in which the acetylation efficiency of αTAT1 is regulated, in part, by the accessibility of acetylation sites through alterations in microtubule structure.
Results
αTAT1 Is Concentrated Near to Microtubule Ends. To investigate the localization of αTAT1 binding to the microtubule, we used total internal reflection fluorescence (TIRF) microscopy to visualize the interactions of purified αTAT1-GFP protein (SI Appendix, Fig. S1A ) with guanosine-5′-[(α,β)-methyleno]triphosphate (GMPCPP)stabilized (nondynamic), rhodamine-labeled microtubules (13) . Here, purified tubulin was combined with the slowly hydrolyzable GTP analog, GMPCPP, and incubated for 2 h. The resulting Significance αTAT1 is an enzyme that acetylates microtubules inside of cells, and acetylation is an important posttranslational microtubule modification. However, microtubules are long tubes, and the acetylation site for αTAT1 is on the inside of this tube. We investigated how αTAT1 enters the microtubule and moves around to access its acetylation sites once inside. We found that αTAT1 enters microtubules through its ends but does not move efficiently inside of the microtubule. However, a lowered affinity allows the enzyme to move more efficiently and leads to longer stretches of acetylation. Therefore, acetylation of microtubules could be controlled in the cell by modulating the affinity of αTAT1 for its acetylation site or increasing the number of microtubule ends. microtubules were then attached to a coverslip in an imaging chamber using antirhodamine antibody, and 30 nM αTAT1-GFP (SI Appendix, Fig. S1 A and C) in imaging buffer was then introduced to the imaging chamber (SI Appendix). After steadystate binding was achieved (∼20 min; SI Appendix, Fig. S1B ), single-time-point images were collected using TIRF microscopy ( Fig. 1A) . Qualitatively, we observed that αTAT1-GFP was concentrated near to the microtubule ends ( Fig. 1B, Top; typical images). We then quantified the microtubule images, and the corresponding green αTAT1-GFP fluorescence, by plotting the average red tubulin and green αTAT1-GFP fluorescence intensity as a function of the distance from the highest red fluorescence intensity (bright) microtubule end to the lowest red fluorescence intensity (dim) microtubule end [ Fig. 1B , Bottom (red, microtubule; gray, αTAT1-GFP) and SI Appendix, Fig.  S2A ]. Here, the "dim" end of the microtubule is likely composed of variable protofilament lengths (26) (27) (28) , and thus may expose the internal microtubule luminal surface (Fig. 1B, cartoon) , an effect that may be enhanced by the microtubule depolymerizing properties of αTAT1 (29) (SI Appendix, Fig. S2C ). We then normalized the green αTAT1-GFP fluorescence intensity to its corresponding red microtubule fluorescence intensity at each microtubule position ( Fig. 1B, Bottom; green markers) to account for reduced total tubulin polymer at the dim microtubule end. We found that the normalized αTAT1-GFP concentration was higher at microtubule ends, and especially on the dim end of the microtubule, which suggests that αTAT1 is concentrated on exposed luminal sites at open, tapered microtubule ends ( Fig. 1B and SI Appendix, Fig. S2 ). To test whether less tapered, "blunt" microtubule tips had reduced targeting of αTAT1-GFP to their ends, we generated a new population of microtubules that were grown for a shorter amount of time (∼10 min), which allowed us to analyze microtubules with reduced taper at the microtubule end (SI Appendix, Fig. S2B ). Consistent with the idea that open, tapered microtubule ends with exposed acetylation sites more readily bind αTAT1 as compared to closed, blunt ends, we observed reduced targeting of αTAT1-GFP on the blunt microtubule tips (SI Appendix, Fig. S2B ).
To confirm that αTAT1 binding was concentrated in areas of the microtubule with exposed luminal sites, we conjugated purified, unlabeled αTAT1 (SI Appendix, Fig. S1A ) to 1.3-nm-diameter gold beads, incubated the αTAT1-conjugated beads with GMPCPPstabilized microtubules for 20 min, and then imaged the microtubules using transmission electron microscopy (TEM) (SI Appendix). The 1.3-nm-diameter beads act as reporters for αTAT1 localization, but they should not limit access to the lumen because they are smaller than the inner diameter of the microtubule (∼15 nm). Consistent with the αTAT1-GFP fluorescence data, 86% of the observed αTAT1-conjugated bead clusters were located either at open microtubule ends or at breaks or openings in the lattice (Fig.  1C , Top; red arrows and bars). This result is in contrast to BSAconjugated control beads, in which 83% of BSA beads did not bind microtubules at all (Fig. 1C , Middle; black Inset), and of the remainder of the BSA beads, 13% were bound to the lattice and 4% to microtubule ends. For a positive control, we then conjugated monomeric (truncated) kinesin-1 to beads, mixed the kinesin beads with microtubules in the presence of adenylyl-imidodiphosphate (AMPPNP) to allow for rigor binding, and then imaged the kinesin beads and microtubules using TEM (30) (Fig. 1C , Middle; blue arrow and bar). We then directly compared the localization of the αTAT1-conjugated beads with the stationary kinesin-conjugated beads (Fig. 1C, Bottom) , and found that although 86% of the bound αTAT1 beads were at microtubule tips or defects, only 15% of the kinesin beads were at tips or defects, with the remainder of the kinesin beads (85%) bound to the closed lattice ( Fig. 1C ). This finding suggests that αTAT1 specifically targeted the beads to open microtubule ends and lattice openings.
Simulations Suggest αTAT1-GFP End-Entry into the Microtubule Lumen. To investigate whether the experimentally observed αTAT1-GFP localization on stabilized microtubules could correlate with a lumen entry mechanism, we performed computational simulations of the αTAT1-microtubule interaction. Our simulations accounted for the (i) association and dissociation of αTAT1 with tubulin subunits on the external surface of the lattice, and diffusion of αTAT1 on this surface ( Fig. 2A , Left; SI Appendix; and SI Appendix, Fig. S3 ), (ii) association and dissociation of αTAT1 on the internal luminal surface of the microtubule and diffusion in solution within the lumen ( Fig. 2A , Center), and (iii) adjusting of the simulated microtubule tip structures to match experimentally observed average microtubule-associated fluorescence lines scans ( Fig. 2A, Right) . We constrained our model parameters either through experiments (SI Appendix, Fig. S3 ), or, alternatively, by testing them over a range of values to ensure that model conclusions did not depend on narrowly defined parameter values (SI Appendix, Fig. S3 ). We found that the modeling results for αTAT1-GFP localization on microtubules were most sensitive to the parameter γ, which controls the αTAT1 off-rate (affinity) on the luminal surface of the microtubule, as described below. We then used the simulation to predict αTAT1-GFP localization for two potential models that explain how αTAT1 could enter into the microtubule lumen (end vs. lattice entry). We first tested a microtubule "lattice entry" model in which simulated αTAT1 could bind the microtubule lattice, and then subsequently enter into the lumen regardless of its position along the microtubule (Fig. 2B ), similar to a "breathing" model in which transient lattice openings could routinely provide access for αTAT1 to enter the lumen along the length of the lattice. Using the lattice entry model, the simulated αTAT1-GFP localization data were not consistent with the experimentally observed localization of αTAT1-GFP at the microtubule tip ( Fig. 2C ). We ran this simulation for multiple values of γ, which is the relative affinity of αTAT1 for α-tubulin Lys40 acetylation sites on the inside surface versus the outside of the microtubule [k off,lumen = γ(k off,lattice )]. We found that the lattice entry model failed to explain the experimental data, regardless of the value for γ ( Fig. 2C ).
Next, we used our simulations to test a microtubule "end-entry" model, in which simulated αTAT1 could only enter the lumen through the microtubule ends (Fig. 2D ). The simulated αTAT1-GFP localization data were consistent with the experimentally observed localization of αTAT1-GFP at the microtubule tip for γ ≤ 0.5 (k off,lumen = 0.5 per second; Fig. 2E ), meaning that the simulated localization of αTAT1-GFP on stabilized microtubules was consistent with the experiment if (i) αTAT1 entered the lumen at microtubule ends and (ii) the simulated off-rate of αTAT1 was twofold higher on the outside of the lattice relative to its acetylation site on the luminal surface of the microtubule (i.e., k off,lumen = 0.5 per second).
Thus, the results from these simulations suggest that the primary mode of αTAT1 entry into the lumen is through the microtubule ends, and that the affinity of αTAT1 for the α-tubulin Lys40 acetylation sites within the lumen is higher than its affinity for the outside of the microtubule. However, our αTAT1-GFP localization studies could not differentiate whether the experimentally observed αTAT1-GFP molecules were on the inside or the outside of the microtubule (Fig. 1B) . Therefore, we used the simulation to predict the pattern of acetylation on the inside of a stabilized microtubule, as would be visualized using a fluorescent antiacetylated tubulin antibody. We found that the lattice-entry model predicted uniformly distributed acetylated tubulin subunits along the length of the microtubule (Fig. 2F , Left Middle and Movie S1) because the αTAT1 molecules that entered the lumen along the length of the microtubule lattice were randomly localized along the inside of the microtubule (Fig. 2F , Left Bottom; cartoon). Conversely, we found that the end-entry simulation predicted concentrated, short "patches" of acetylation at microtubule ends ( Fig. 2F , Right Middle and Movie S2). These patches were predicted because the αTAT1 molecules that entered the lumen through the microtubule ends tended to remain near to the microtubule ends ( Fig. 2F , Right Bottom; cartoon).
In the end-entry αTAT1 simulation, the luminal αTAT1 molecules remained near to the microtubule ends because the simulated αTAT1 molecules exhibited very slow mobility inside of the microtubule lumen. Although it is expected that αTAT1 should diffuse rapidly in solution within the lumen, the concentration of α-tubulin Lys40 binding sites inside of the lumen is very high due to the small volume and dense packing of tubulin subunits inside the lumen (∼17 mM; calculated in SI Appendix). This high concentration of α-tubulin Lys40 binding sites within the lumen makes the effective on-rate for an individual αTAT1 molecule inside of a microtubule also very high. For example, we predict that the typical rebinding time for a free αTAT1 molecule inside the lumen will be (1/(k on [binding sites])) = 6 × 10 −5 per second (using a diffusionlimited biomolecular on-rate constant of k on = 1 μM −1 ·s −1 ) (31). As a result, we further predict that the root mean squared travel distance for a free αTAT1 molecule before rebinding to an α-tubulin Lys40 acetylation site (Δx lumen ) would be ∼50 nm, where <Δx 2 lumen > 1=2 = ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi 2D lumen Δt rebind p , [1] in which D lumen is the αTAT1 diffusion coefficient in solution (∼2.6 × 10 7 nm 2 ·s −1 ) (18) and Δt rebind is the typical rebinding time, as calculated above (∼6 × 10 −5 s −1 ). This predicted mean travel distance is similar to previous computational predictions (32) . Thus, the end-entry model for αTAT1 predicts that there will be patches of acetylated tubulin near to the αTAT1 entry point at microtubule ends because the mobility of αTAT1 within the lumen may be limited by rapid rebinding of luminal αTAT1 to nearby tubulin subunits ( Fig. 2G) , with patch length further limited by a slow luminal off-rate (SI Appendix, Fig. S3C ; simulated k off,lumen = 0.5 per second). This behavior led to two key predictions from the simulation that could be tested experimentally. First, if the endentry model is correct, then acetylation should be most commonly observed near to the ends of the microtubules, where αTAT1 routinely enters the lumen. Second, if there is slow mobility of αTAT1 inside of the microtubule lumen due to rapid rebinding, then concentrated patches of microtubule acetylation should be observed, rather than a uniform dispersion of acetylation along the length of the microtubule (Fig. 2G ).
Microtubule Acetylation Occurs in Patches at Microtubule Ends. We experimentally tested these simulation predictions by visualizing fluorescently labeled antiacetylated tubulin antibodies on rhodaminelabeled, GMPCPP-stabilized microtubules. Here, GMPCPPstabilized microtubules were adhered to flow chamber coverslips as described above. A mixture of 2.5 μM unlabeled αTAT1, 2 mM acetyl CoA (AcCoA), and Brb80 was then introduced into the imaging chamber and incubated with the coverslip-adhered microtubules for 30 min (Fig. 3A, Left) . Then, the αTAT1 mixture was gently flushed from the chamber, and imaging buffer with CF488-labeled antiacetylated tubulin antibody was introduced to the chamber. The fluorescent antiacetylated tubulin antibody and microtubules were then imaged using TIRF microscopy (Fig. 3A , Left and Materials and Methods). We observed acetylation patches at the ends of microtubules ( Fig. 3A , Right Top), similar to the simulation predictions for the end-entry model ( Fig. 2F , Right; white arrow). The patches, which were defined as an area of fluorescent antibody localization along the length of the microtubule lattice, averaged ∼300 nm in length. This length represents up to ∼200 acetylated tubulin subunits [= ((300 nm − 170 nm point spread function)/(8 nm/layer)) * (13 subunits/layer)]. Less frequently, we also observed patches within the microtubule lattice ( Fig. 3A , Right Bottom). To quantify this observation, we calculated the patch frequency per site by normalizing the patch frequency to the number of available sites in each case, where end sites represented the last 128 nm (two pixels) of a microtubule at each end and lattice sites represented the remainder of the microtubule. Similar to the predictions from our simulation, we found that patches were 15-fold more likely to occupy microtubule end sites than microtubule lattice sites ( Fig. 3B ; binomial test, P < 2 × 10 −6 ). Further, we measured the fluorescence intensity of the microtubule lattice at internal acetylation spots, and, consistent with the idea that internal acetylation may be correlated with broken microtubules, defects, or distinct microtubule ends, internal patches of acetylation were more frequently localized to dim areas on the microtubule compared with the mean microtubule brightness ( Fig. 3B , Inset; binomial test, P = 3.4 × 10 −5 ).
To ensure that the antibody itself was not limited in its mobility to travel within the lumen, leading to an inability to detect acetylation along the length of the microtubules, we performed a positive control experiment. Here, dynamic microtubules were grown in the presence of αTAT1 and AcCoA, in contrast to the stabilized microtubule experiments above, in which αTAT1 and AcCoA were added to preformed microtubules ( Fig. 3C , Left vs. Fig. 3A ). After 30 min of growth and acetylation, the dynamic microtubules were then stabilized with Taxol, introduced to an Norm. anƟ-acetyl Band Int. imaging chamber, and imaged with the fluorescent antiacetylated tubulin antibody ( Fig. 3C, Left) . We observed a population of microtubules that were uniformly labeled with antibody over their entire lengths ( Fig. 3C , Right Top), indicating that the antibody was indeed able to access a uniform proportion of the acetylated sites in the microtubules. To quantify this observation, average line scans for similar length, fully acetylated microtubules in the positive controls were collected. We found that the antibody brightness was uniform along the length of the microtubule for the fully acetylated controls ( Fig. 3C , Right Bottom), indicating that the fluorescent antibody brightness as visualized by TIRF microscopy was similar whether the antibody reported acetylated tubulin subunits near to the ends of the microtubules or inside of the lumen along the length of the microtubule.
Acetylation at Microtubule Ends Increases over Time. To test whether increased αTAT1 incubation time would increase the frequency of the acetylation patches, we incubated stable, preformed microtubules with 2.5 μM αTAT1 for times ranging from 5 to 120 min and then visualized microtubule acetylation with fluorescent antiacetylation antibody. We found that the fraction of microtubules with acetylation patches at their ends increased over time ( Fig. 3D , Top and SI Appendix, Fig. S4B ), and we note that a similar trend was observed with increasing αTAT1 concentrations in which incubation time was held constant at 30 min ( Fig. 3D , Bottom and SI Appendix, Fig. S4A ). Thus, increasing the αTAT1 incubation time ( Fig. 3D , Top) or concentration ( Fig. 3D , Bottom) led to a higher overall acetylation level due, in part, to an increased fraction of acetylated microtubule ends, consistent with an end-entry model. As indicated by the nonzero intercept in the frequency graphs in Fig. 3D (Top), we noted that a fraction of the microtubules displayed acetylation patches at their ends very quickly, followed by a slower increase over time for the remainder of the microtubules (P = 0.0006, linear regression). We hypothesize that the fraction of microtubule ends that were very quickly acetylated had readily accessible acetylation sites (e.g., via open, tapered ends), whereas the more slowly acetylated ends required rate-limiting entry of αTAT1 into the microtubule through blunt ends, consistent with our observation that tapered microtubule ends have increased targeting of αTAT1-GFP relative to blunt ends ( Fig. 1B vs. SI Appendix, Fig. S2B ). If higher acetylation levels over time were due, in part, to an increased number of acetylated microtubule ends, and particularly to an increased number of tapered or opened microtubule ends, we reasoned that bulk acetylation levels would increase if the number of microtubule ends and/or lattice openings were increased by mechanical shearing and breaking of the microtubules. To test this prediction, we mixed rhodamine-labeled, GMPCPP-stabilized microtubules with unlabeled αTAT1, separated half of the mixture, and sheared it using a small-diameter needle (1× shear). After a 120-min incubation time, we sheared a portion of the 1× mixture a second time (2× shear), and then allowed the 2× shear mixture to incubate for an additional 60 min. We quantified the acetylation levels for both mixtures using western blots, and then normalized each antiacetylation band intensity to its tubulin loading control to account for loss of microtubules inside of the syringe during the shearing process ( Fig. 3E , Top). We found that the microtubule acetylation levels were slightly higher for the 1× sheared mixture relative to its nonsheared control (P = 0.2) and that the 2× sheared mixture was substantially more acetylated than its unsheared control (P = 0.07; Fig. 3E , Bottom). This finding suggests that the microtubules were broken into smaller fragments and/or damaged by successive cycles of shearing, which generated new microtubule ends and/or openings in the lattice during each cycle, and thus allowed for more acetylated microtubule ends and/or lattice openings. The increase in acetylated microtubule ends then led to a higher bulk acetylation level (16) . Thus, microtubule acetylation may be facilitated by increased numbers of microtubule ends or new lattice openings.
Microtubule Acetylation Is Facilitated by New Lattice Openings. In addition to mechanical shearing, another method for allowing access of αTAT1 to the microtubule lumen may be by introducing large breaks or openings within the microtubule wall ( Fig. 4A ). Thus, we predicted that by opening up the closed tube, or by introducing breaks into the tube, increased numbers of acetylation patches would be observed along the length of the microtubule lattice, and there would be an increase in the bulk acetylation level of a microtubule population ( Fig. 4B ). It has been previously demonstrated that opened, damaged microtubules can be created by briefly exposing GMPCPP microtubules to calcium (33) . Therefore, rhodamine-labeled GMPCPP microtubules were briefly incubated with 40 mM CaCl 2 , and the CaCl 2 -treated microtubules were imaged with TEM ( Fig. 4C , Top and SI Appendix). From the TEM images, it was clear that portions of the GMPCPP microtubules were opened and/or damaged through the CaCl 2 treatment (Fig. 4C , Top), which should allow increased access of αTAT1 to its acetylation site inside the microtubule lumen. Therefore, coverslip-adhered CaCl 2 -treated microtubules were incubated with unlabeled αTAT1 in an imaging chamber for 30 min, and acetylation was then imaged with antiacetylated tubulin antibody (Fig. 4C, Bottom) . We found that CaCl 2 treatment substantially increased both the number of patches per microtubule (Poisson regression, P < 2.2 × 10 −16 ) and the fraction of microtubules with patches (two-sample test of proportions, P < 2.2 × 10 −16 ) ( Fig. 4D and SI Appendix, Fig. S4F ).
To confirm that the antiacetylated tubulin antibody was properly reporting the acetylation of CaCl 2 -treated microtubules, we performed a parallel experiment using western blots. Acetylated tubulin levels were measured over time for control and CaCl 2 -treated microtubules ( Fig. 4E , Top and SI Appendix, Fig. S4E ), and the normalized band intensities were plotted as a function of αTAT1 incubation time ( Fig. 4E, Bottom) . We found that the αTAT1 acetylation level after 60-90 min of αTAT1 incubation time was 3.7-fold higher for CaCl 2 -treated microtubules compared with control microtubules [ Fig. 4E ; green, CaCl 2 ; red, controls (also plotted alone in SI Appendix, Fig. S1C ); log-transformed linear regression, P = 0.003], consistent with our fluorescence studies (Fig. 4D ). In addition, we found that αTAT1 does not acetylate tubulin dimers as efficiently as it does intact microtubules, consistent with previous αTAT1 studies (18, 19) (Fig. 4E, blue) .
Together, these results are consistent with the prediction that αTAT1 relies on microtubule ends and breaks or openings in the microtubule lattice to allow access to the lumen. Acetylation of stable microtubules may be limited both by αTAT1 entry into the lumen and by αTAT1 mobility within the lumen. To test αTAT1 mobility within the lumen, stabilized microtubules were incubated with αTAT1 for 5 or 120 min, and acetylation was visualized with fluorescently labeled antibody using TIRF microscopy as described above (Fig. 5A , Left). The overall increase in the fraction of acetylated tubulin subunits per (acetylated) microtubule was then assessed by reporting the acetylation patch lengths on individual microtubules, normalized to microtubule length. We found that the fraction of acetylation per microtubule increased slightly but significantly when the αTAT1 incubation time was increased from 5 to 120 min ( Fig. 5A, Middle) . We found a similar small increase when the αTAT1 concentration was increased from 2.5 to 3.5 μM ( Fig. 5A , Right; αTAT1 incubation time of 30 min). This finding suggests that αTAT1 is able to acetylate new tubulin subunits continually within the lumen, but at a slow pace. The slow pace of acetylation may be due, in part, to slow diffusion of αTAT1 within the lumen, although, as previously reported (29) , the presence of αTAT1 leads to slow microtubule depolymerization (SI Appendix, Figs. S2C and S4 C and D), which also likely causes preferential loss of acetylation patches at microtubule tips over time, leading to an underestimate of patch length growth over time.
Thus, to measure the mobility of αTAT1 within the microtubule lumen more directly, 15 nM αTAT1-GFP protein was added to an imaging chamber with stabilized microtubules, and singlemolecule movies were then collected using fast time-lapse TIRF microscopy (20 frames per second). We observed both slow-and fast-moving αTAT1-GFP molecules (Fig. 5B, Left) , which led to a wide range of measured diffusion coefficients ( Fig. 5C , pink circles). We predicted that there may be a wide range of diffusion coefficients because, although many of the αTAT1-GFP molecules were bound to and diffusing on the outer lattice (16), some of the αTAT1-GFP molecules could have entered the microtubule lumen; thus, these molecules would reflect the mobility of αTAT1-GFP within the lumen. To evaluate the mobility of lumen-trapped αTAT1-GFP, we incubated αTAT1-GFP with coverslip-adhered microtubules and then washed the imaging chamber with warm buffer to remove the lattice-bound molecules, presumably leaving behind a portion of the lumen-trapped αTAT1-GFP molecules. We then used fast time-lapse microscopy to collect movies of the microtubule-associated αTAT1-GFP molecules that remained behind ( Fig. 5B, Right) . Importantly, we did not observe any fast-diffusing αTAT1-GFP molecules after the washout, and, as a result, the postwashout diffusion coefficient for microtubule-associated αTAT1-GFP molecules was over an order of magnitude smaller than the prewashout diffusion coefficient ( Fig. 5C ). This result suggests that after washout, the αTAT1-GFP molecules that may have been trapped within the lumen remained behind, and that these molecules had limited mobility, consistent with our fluorescent acetylation data and modeling work. This result is in contrast to recent work by Szyk et al. (18) , which suggested that luminal αTAT1 was able to scan the length of the microtubule quickly. However, although our experimental prewashout measurements for the diffusion coefficient of αTAT1 on the microtubule lattice were similar to the prewashout measurements reported by Szyk et al. (18) , αTAT1 has been reported to interact electrostatically with the outside of the microtubule lattice (16) , and so we surmised that our prewashout diffusion coefficient largely reflected αTAT1 diffusion on the outside of the microtubule. This argument is consistent with our observations of diffusing αTAT1-GFP molecules "jumping" from one microtubule to another on the exterior surface of the microtubule in the prewashout movies ( Fig. 5D and Movie S3).
Acetylated Patch Length Increases with Increasing Salt Concentration.
Our results are consistent with a model in which αTAT1 exhibits slow and impeded mobility inside of the microtubule lumen. This slow and impeded mobility may be due to rapid rebinding of αTAT1 to densely packed acetylation sites, as well as to a slow luminal αTAT1 off-rate. Therefore, we reasoned that if the αTAT1 rebinding rate was suppressed and the off-rate was increased, this net decrease in affinity for the αTAT1 luminal acetylation site should lead to increased αTAT1 mobility within the lumen, and subsequently to longer patches of microtubule acetylation. Consistent with this hypothesis, our simulations predicted that larger mean travel distances between rebinding events <Δx lumen > for luminal αTAT1 molecules would lead to longer simulated acetylation patch lengths ( Fig. 6 A-C and SI Appendix).
To test this prediction, we noted that it has been previously demonstrated that the binding affinity of αTAT1 for microtubules is suppressed at higher salt concentrations (16) . Therefore, if the slow mobility of αTAT1 inside of the microtubule lumen is due to rapid high-affinity binding to densely packed tubulin subunits, we predicted that by adding salt during αTAT1 incubation, a net decrease in αTAT1 affinity for the microtubule could lead to longer acetylation patch lengths. Thus, we performed the acetylation-TIRF experiments, but by adding different concentrations of KCl during αTAT1 incubation. Strikingly, patch lengths were approximately threefold longer if the αTAT1 incubation was carried out at highsalt conditions relative to our previous no-salt-added conditions ( Fig. 6 D and E; two-sample t test, P = 5.2 × 10 −12 ), whereas the size of αTAT1 itself remained unchanged (Fig. 6E, Inset) . This result supports a model in which the mobility of αTAT1 within the microtubule lumen is controlled by its affinity to the densely packed acetylation sites within the lumen (Fig. 6F) , and that reduced affinity in experiments with higher ionic strength allowed for increased mobility of αTAT1 within the lumen.
Reduced αTAT1 affinity for its acetylation binding site via increased ionic strength could explain, at least in part, the increased efficiency of αTAT1 mobility in the experiments of Szyk et al. (18) compared with the data presented here. TIRF acetylation experiments in the report by Szyk et al. (18) were performed with 50 mM added KCl, which would be expected to increase acetylation patch lengths: as shown in Fig. 6E , we found that there was an approximately twofold increase in acetylation patch lengths with 50 mM added KCl compared with the "no-KCl-added" conditions in our baseline experiments.
Discussion
On the basis of our αTAT1-GFP localization data, computational simulations, biochemical experiments, and acetylation localization data, we conclude that the foremost mode of entry for αTAT1 into the microtubule lumen is through the microtubule ends, or through bends and breaks in the microtubule wall. This conclusion is in contrast to the model from Shida et al. (13) , which suggested that αTAT1 may access the microtubule lumen through regular lattice breathing at any position along the lattice, but is consistent with findings from Akella et al. (12) , in which the Lys40 acetylation signal formed a decreasing gradient that peaked at microtubule ends in axonemes. We also found that once αTAT1 enters the microtubule lumen, it moves slowly down the lumen, and that this mobility is controlled by the affinity of αTAT1 for the highly concentrated α-tubulin acetylation sites within the lumen. This impeded mobility leads to concentrated patches of microtubule acetylation at the ends of stable microtubules. Our results suggest that αTAT1 enters the microtubule ends and preferentially acetylates these ends because αTAT1 is not able to diffuse efficiently within the lumen. This conclusion is in contrast to recent work by Szyk et al. (18) , which suggested that a high concentration of αTAT1 was able to acetylate an entire microtubule almost simultaneously through longer acetylation bursts that occurred randomly along the microtubule length (18) . Although one difference between our studies was in the ionic strength of the buffers, we also noted that a potentially important difference between the two studies was that we used GMPCPPstabilized microtubules to analyze acetylation patterns on preformed microtubules, whereas Szyk et al. (18) used Taxol-stabilized microtubules. Both the timing and method of Taxol introduction have been shown to affect the structure of Taxol microtubules (34) . Our work has demonstrated that microtubule structure, and particularly the presence of defects and openings in the microtubule lattice, would have a substantial impact on the efficiency of αTAT1 in accessing and acetylating luminal acetylation sites. As shown in SI Appendix, Fig. S5 , we found that one-step microtubule stabilization by Taxol may lead to more open, sheet-like microtubule structures, thus facilitating direct access of αTAT1 to its acetylation site and potentially leading to a more disperse acetylation pattern. Therefore, differences in the microtubule stabilization technique, in addition to the experimental ionic strength, may contribute to differing acetylation patterns between this study and the study of Szyk et al. (18) .
Our results are consistent with a model in which αTAT1 stochastically enters microtubule ends. Thus, if αTAT1 never enters a microtubule end, the microtubule could remain unacetylated, even when nearby microtubules are partially or even fully acetylated. However, in stable cellular microtubule networks, where the t 1/2 of some microtubules is ∼2.2 h (35), such as in neurons, it is more likely that αTAT1 would ultimately enter the ends of a larger fraction of the microtubules, given their long lifetimes. Then, αTAT1 may be able to acetylate the stable microtubules slowly while traveling down the lumen, especially under high-salt conditions such as is present inside of cells (Fig. 6F) . In addition, we demonstrated that disruption of microtubule structure leads to an increase in microtubule acetylation ( Figs. 3E and 4 B-E), and that acetylation often occurs at breaks in the microtubule lattice ( Fig. 4A ), suggesting that microtubule bending and breaking may provide secondary αTAT1 entry points to the lumen inside of cells. In cells, stable microtubule networks might naturally accumulate more lattice breaks because of their long lifetimes, and so this enhanced accumulation could also contribute to an increase in overall acetylation of stable microtubule networks, as well as to the discontinuous staining of acetylated tubulin as has been observed in cells (21, 24, 25, 36, 37) .
Other cellular influences may also have an impact on the efficiency of αTAT1 acetylation in vivo. For instance, Kalebic et al. (29) found that αTAT1 autoacetylation significantly increases the catalytic activity of αTAT1. Autoacetylation of αTAT1 could potentially increase the mobility of αTAT1 within the lumen, perhaps by suppressing the binding affinity of αTAT1 for its acetylation site. Additionally, Montagnac et al. (38) found that clathrin-coated pits localize αTAT1 to the ends of growing microtubules, which would subsequently increase the opportunity for αTAT1 to enter the lumen. This αTAT1 localization led to stretches of acetylation near to the microtubule end, similar to what we observed in our in vitro studies. Thus, factors that localize αTAT1 to microtubule plus-ends could also increase the efficiency of αTAT1 acetylation in vivo.
In summary, our data support a model in which αTAT1 stochastically enters the lumen at microtubule ends, or through breaks in the lattice. Then, the mobility of αTAT1 within the lumen is controlled by the affinity of αTAT1 for its binding sites, which are highly concentrated within the lumen. Important future efforts will involve identifying regulators of αTAT1 that could facilitate its end-entry and luminal mobility, as well as studies to determine whether αTAT1 itself could potentially modulate microtubule dynamics to allow access to the lumen.
Materials and Methods
Experimental. αTAT1 proteins were expressed in Escherichia coli cells, and the interactions with reconstituted microtubules were then visualized using either TIRF microscopy or western blots as described in SI Appendix.
Simulation. Simulation code was written in MATLAB (MathWorks), and then run on personal computers as described in SI Appendix. 
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Coombes et al. 10 .1073/pnas.1605397113 Movie S1. Simulation of real-time acetylation: lattice-entry model. This simulation demonstrates (i) the dynamics of simulated αTAT1-GFP with a red stabilized microtubule (Top; microtubule, red; αTAT1-GFP, green), (ii) the associated pattern of acetylation as viewed by a simulated antiacetylated tubulin antibody (Middle; microtubule, red; antiacetyl antibody, blue), and (iii) a schematic output of the process (Bottom), in which microtubule protofilaments are shown in red; αTAT1 on the external surface of the microtubule is shown in green; and αTAT1, which has entered into the microtubule lumen, is shown in blue. Simulation length is 20 min real time.
Movie S1
Movie S2. Simulation of real-time acetylation: end-entry model. This simulation demonstrates (i) the dynamics of simulated αTAT1-GFP with a red stabilized microtubule (Top; microtubule, red; αTAT1-GFP, green), (ii) the associated pattern of acetylation as viewed by a simulated antiacetylated tubulin antibody (Middle; microtubule, red; antiacetyl antibody, blue), and (iii) a schematic output of the process (Bottom), in which microtubule protofilaments are shown in red; αTAT1 on the external surface of the microtubule is shown in green; and αTAT1, which has entered into the microtubule lumen is shown in blue. Simulation length is 20 min real time.
Movie S2
Movie S3. Diffusion of αTAT1-GFP on GMPCPP-stabilized microtubules. The movie shows a microtubule in red, and fluorescent αTAT1-GFP in green. Timelapse images are collected every 380 ms. In this movie, motile αTAT1 GFP lands on a microtubule, diffuses, and then suddenly "jumps" to a nearby microtubule, consistent with diffusion on the external surface of the microtubules. The strongest effect on patch length is the luminal αTAT1 step sizes prior to rebinding (<Δx lumen >) (blue line). For the luminal αTAT1 off-rate, the patch lengths approach the maximal values allowed by the set value for <Δx lumen > when γ>0.1. Therefore, low luminal off-rates can limit patch length to below the maximum value allowed by <Δx lumen > (red line), however, increased (long) patch lengths result from increasing step sizes prior to rebinding (e.g., by <Δx lumen >), which represents travel distance prior to rebinding. (D) The rate of enzymatic activity was not directly included as a free parameter in the simulations, rather, we added a finite probability for whether the visit of an αTAT1 molecule to an unacetylated tubulin dimer would result in an acetylation event. The length of the simulated acetylation patches was not sensitive to the enzymatic rate: while the patch intensity increased more slowly over time if there was a 10% probability of acetylation per visit as compared to a 100% probability, the length of the acetylation patch after a given amount of time did not depend on enzymatic rate. This is because, in the simulation, the patch length is dependent on the mobility of the enzyme to travel down the lumen, regardless of whether all visits resulted in an acetylation event. Fig. 5A were normalized to microtubule length in each case to account for this effect. (E) Acetylation rates of intact GMPCPP microtubules and calcium-treated GMPCPP microtubules were compared using western blots. Western blots of acetylated microtubules and calcium treated microtubules demonstrate an increased acetylation rate on calcium treated microtubules. (F) Effect of calcium treatment on burst length and burst localization in our acetylation TIRF experiment was assessed. Only small differences were found between GMPCPP microtubules and calcium treated GMPCPP microtubules. S u p p l e m e n t a l M a t e r i a l P a g e | 9
Movie S3
Mechanism of Microtubule Lumen Entry for the α-Tubulin Acetyltransferase Enzyme αTAT1
Experimental Methods
Purification of αTAT1 and αTAT1-GFP
A plasmid, pGEX-GST-αTAT1, was purchased from Addgene.org (#27101) and transformed into Rosetta high protein expression E.coli (EMDMillipore, #71397)). GFP was also ligated into this plasmid to create pGEX-GST-GFP-αTAT1. E. coli containing these plasmids were grown in 10ml of LB+amp+cam media at 37° overnight, subcultured 1:200 into 500ml of fresh media and grown for 3.5hr at 37° until an A600 of 0.58. IPTG was then added to 1mM final and the cultures continued growth at 18° for 16hr. Cultures were centrifuged and the cell pellets resuspended in 16ml lysis buffer (50mM Tris pH 75, 150mM NaCl, 1% triton X-100, 10% glycerol, 2mM DTT, 2mM AEBSF, 4mg/ml lysozyme and mixed at 90min at 30°. The cell suspension was then frozen drop-wise in liquid nitrogen and the frozen beads were ground multiple times in a coffee grinder. Lysate was centrifuge at 18000xg for 1hr at 4° and the supernatant was mixed with 250ul of PBSwashed glutatione-sepharose 4B beads (GE Healthcare, #17-0756-01) for 2.5hr and 4°. Beads were then washed 4x with 3ml of lysis buffer, resuspended in 1ml lysis buffer + 12ul of Prescission protease (GE Healthcare, #27-0843-01) and mixed at 4° for 20 hrs to release the αTAT1 from the GST tag and beads (Fig.  S1 ).
αTAT1 Size Analysis
Protein size distribution was determined by measurement on a Microtrac Nanoflex particle analyzer, a device that uses dynamic light scattering of a laser in solution to determine particle size. Purified αTAT1 was measured on the Nanoflex in the same buffers and concentrations that were used in the lumen diffusion analysis: αTAT1 at 156 nM in Brb80 buffer + 2 mM acetyl-CoA with and without 100 mM KCl.
In vitro Microtubule-αTAT1-GFP Experiments, Imaging, and Analysis
GMPCPP Microtubules
To make stabilized GMPCPP microtubules, a 45 μL solution which consisted of 3.9 µM tubulin (25% rhodamine-labeled, 75% unlabeled) and 1 mM GMPCPP in BRB80 was mixed and kept on ice for 5 min, then incubated at 37 o C for 10 minutes to 2 hours. Following incubation, the seeds were diluted into 400 µL warm BRB80, and 350 µL of this dilution was spun down in an air-driven ultracentrifuge @ 20 psi for 5 min. The supernatant was discarded, and the pellet resuspended into 400 µL warm BRB80. To further stabilize the microtubules, Taxol was added to a final concentration of 10 µM Taxol.
Construction and Preparation of Flow Chambers for Imaging
Imaging flow chambers were constructed as in Section VII of Gell et al. 2010 (1) , with the following modifications: two narrow strips of parafilm replaced double-sided scotch tape as chamber dividers: following placement of the smaller coverslip onto the parafilm strips, the chamber was heated to melt the parafilm and create a seal between the coverslips; typically only three strips of parafilm are used, resulting in two chambers per holder. Chambers were prepared with anti-rhodamine antibody followed by blocking with Pluronic F127, as described in Section VIII of Gell et al. 2010 (1) .
αTAT1-GFP Binding Assay and Imaging
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A flow chamber was prepared as described above. GMPCPP microtubules were adhered to the chamber coverslip, and the chamber was flushed gently with warm BRB80. The flow chamber was heated to 28°C using an objective heater on the microtubule stage, and then 3-4 channel volumes of imaging buffer containing 110 μg/ml Glucose Oxidase, 20 μg/ml Catalase, 20 nM D-Glucose, 10 mM DTT, 0.1 mg/ml Casien, and 1% Tween-20, were flushed through the chamber. A reaction mixture containing the imaging buffer and .08 to 100 nM final concentration of αTAT1-GFP (Experiments in Fig. 1 use 30 nM) was prepared, centrifuged for 5 min at 4 °C, and then the supernatant was immediately introduced into the imaging chamber, with drops left at the flow chamber ends to keep the flow chamber from drying out during imaging.
After 10 minutes, αTAT1-GFP binding on GMPCPP microtubules was imaged on a Nikon TiE microscope using 488 nm and 561 nm lasers sent through a Ti-TIRF-PAU for Total Internal Reflectance Flourescence (TIRF) illumination. An Andor iXon3 EM-CCD camera fitted with a 2.5X projection lens was used to capture images with high signal to noise and small pixel size (64 nm). Images were collected using TIRF with a Nikon CFI Apochromat 100X 1.49 NA oil objective. Images for tip structure/αTAT1-GFP binding analysis were single time points only, to avoid complications from photobleaching.
αTAT1-GFP Binding Assay Image Analysis
The single time point images of GMPCPP microtubules with αTAT1-GFP were cropped to separate each microtubule into a single image using ImageJ. Then, integrated and averaged line scans of each microtubule image were created using a MATLAB script. In each case, the microtubule was aligned with the "dim" fluorescence end on the right, and then the red and green fluorescence were plotted as a function of microtubule length from microtubule bright end to microtubule dim end. To do this, the red tubulin fluorescence was integrated along the length of each microtubule ± 256 nm above and below the microtubule centerline to account for point spread function and variability in properly finding the microtubule centerline. Then, the red fluorescence intensity was summed over the last 576 nm on both ends of the microtubule. The lower summed value was considered the "dim" microtubule end, while the higher summed value was deemed the "bright" microtubule end. Scatter plots were created by importing the integrated line scan fluorescence data into Excel.
αTAT1-GFP Imaging to Evaluate Diffusion Coefficients
To image diffusion of αTAT1-GFP molecules, a flow chamber with stabilized GMPCPP microtubules adhered to the coverslip was prepared as described above, and a reaction mixture containing the imaging buffer and 15 nM final concentration of αTAT1-GFP was then prepared and immediately introduced to the imaging chamber. Images were taken at 20 frames per second to capture diffusion of αTAT1 molecules.
For wash-out experiments, the flow chamber and αTAT1-GFP mixture was prepared as above, and introduced to an imaging chamber. After incubation to allow binding of αTAT1-GFP to the microtubules, the imaging chamber was then flushed with imaging buffer that contained 0.1 M KCl. Then, a low salt imaging buffer (as described above) was added to the chamber. Images were taken at 20 frames per second to capture diffusion.
αTAT1-GFP Image Analysis and Computation to Evaluate Diffusion Coefficients
Kymographs were created from the movies using a custom MATLAB (2015a, Mathworks) script. The αTAT1-GFP traces within the kymographs were analyzed for diffusion using a custom MATLAB script as follows. A region of the kymograph without GFP signal was designated as background. Next, the position of an αTAT1-GFP molecule over time was traced roughly by hand to provide a starting point for the fitting algorithm. In order to prevent nearby molecules from affecting the fitting, a width was defined outside of which all intensities are set to be equal to the median intensity of the background region defined previously. This region slides with the hand-traced center of the αTAT1-GFP intensity, minimizing interfering signal while maintaining all of the signal of interest. The sub-pixel location of the αTAT1-GFP was then determined through 1-dimensional Gaussian fitting of each time point of the kymograph. The diffusion coefficient was then calculated by taking the slope of the mean-squared-displacement of the position with respect to the time interval, and dividing by 2n, where n is the dimensionality of the diffusion, in this case n is 1. The units were then converted from pixels and frames to μm and seconds, respectively, based on the known pixel size of the microscope and the frame-rate.
αTAT1 and BSA Conjugation to Gold Beads
αTAT1 and BSA were conjugated to 20nm gold beads with the Innovacoat 20nm gold particle labeling kit (Innova Biosciences, #229-0005) as per instructions, except that the αTAT1 was buffer-exchanged beforehand into PBS with Microcon Ultracel YM-3 microcentrifuge filter concentrators. For labeling proteins with 1.3 nm gold particles, buffer exchanged αTAT1 was reacted for 1.5 hr with mono-sulfo-NHS-nanogold 1.3 nm particle reagent as per instructions (nanoprobes #2025A) and excess particles were washed out by 2wash/centrifugations in Amicon Ultra 0.5ml 30k filter units, diluting with PBS.
αTAT1-conjugated gold beads (1.3 nm and 20 nm) were incubated with GMPCPP microtubules and Acetyl CoA (2 mM final concentration) for 20 minutes and imaged using Transmission Electron Microscopy. BSAconjugated gold beads (1.3 nm and 20 nm) were incubated with GMPCPP microtubules and Acetyl CoA (2 mM final concentration) for 20 minutes and imaged using Transmission Electron Microscopy.
Transmission Electron Microscopy
Reaction mixtures were prepared as described for each experiment. A drop of the reaction mixture was placed on a 300-mesh carbon coated copper grid for 1 minute. At 1 minute, the grid was stained with 1% uranyl acetate for 1 minute. The stain was then wicked away with filter paper and the grid was left to dry and then stored. Specimens were observed using an FEI Technai Spirit BioTWIN transmission electron microscope. Images were recorded at 15,000X-23,000X at -3 to -5 defocus.
Fluorescence Microtubule Acetylation Assay
Calcium Treated GMPCPP Microtubules GMPCPP Microtubules were incubated with .04 M final concentration of CaCl 2 for 40 minutes at 37˚C. Calcium treated GMPCPP microtubules were then adhered to an imaging flow chamber as described above. A mixture of αTAT1-GFP in imaging buffer was flushed into the flow chamber and imaged as described above.
Closed Taxol Microtubules
To make Closed Taxol microtubules, a mixture composed of 33 µM tubulin (25% rhodamine-labeled, 75% unlabeled), 1 mM GTP, 4 mM MgCl 2 , and 4 % DMSO was prepared and kept on ice for 5 min, and then incubated at 37 o C for 30 minutes. Following incubation, the microtubules were diluted into 990 µl warm Taxol solution (10 μM Taxol with Brb80) and stored overnight at 37 o C. Taxol microtubules were spun down in an air-driven ultracentrifuge @ 20 psi for 5 min and resuspended in 50 μl warm 10 μM Taxol Brb80 buffer before use in assays.
Open Taxol Microtubules
To make Open Taxol microtubules, a mixture composed of 33 µM tubulin (25% rhodamine-labeled, 75% unlabeled), 1 mM GTP, 4 mM MgCl 2 , and 4 % DMSO was prepared and kept on ice for 5 min, and then incubated at 37 o C for 30 minutes. Following incubation, the microtubules were diluted into 990 µl warm Taxol solution (10 μM Taxol with Brb80). To make Open Taxol microtubules, the microtubules were either used immediately, or else stored overnight at room temperature.
αTAT1 Acetylation Assay and Imaging GMPCPP, Calcium Treated, Closed Taxol, or Open Taxol microtubules were adhered to flow chamber coverslips as described above. A mixture of unlabeled αTAT1 (2.5-5.5 μM, designated in text), Acetyl CoA (2 mM final concentration), KCl (0-100 mM, designated in text), and Brb80 was flown in to the chamber and incubated for 5-120 minutes (designated in text). Then, imaging buffer with CF4-88 labeled anti-acetylated tubulin (6-11B-1, Sigma Aldrich cat. #T7451-200L; 80 μM) was flown in to the chamber as described above and imaged using TIRF microscopy as above.
αTAT1 Acetylation of Dynamic Microtubules Assay and Imaging
A mixture composed of 45 µM tubulin (25% rhodamine-labeled, 75% unlabeled), 1 mM GTP, 4 mM MgCl 2 , 4 % DMSO, 1.8 μM αTAT1, and 2 mM Acetyl CoA was prepared and kept on ice for 5 min, and then incubated at 37 o C for 30 minutes. Following incubation, the microtubules were diluted into 990 µl warm Taxol solution (10 μM Taxol with Brb80). The microtubules were adhered to flow chamber coverslips. Then, imaging buffer with CF4-88 labeled anti-acetylated tubulin (6-11B-1, Sigma Aldrich cat. #T7451-200L; 80 μM) was flown in to the chamber as described above and imaged using TIRF microscopy as above.
Acetylation Patch Image Analysis
The single time point images of GMPCPP microtubules with anti-acetyl antibody were cropped to separate each microtubule into a single image using ImageJ. Then, a MATLAB script was used to measure the location and length of acetylation "patches" on the microtubules by manual clicking. In each case, the patch positions were measured relative to the bright microtubule end and the dim microtubule end, with assignment of "bright" and "dim" ends as described above. Patches that occupied the first two pixels from each microtubule end were said to occupy a "tip" site, and patches occupying any other pixels along the microtubule were labeled "lattice" sites. The patch frequencies of tip and lattice sites were calculated by normalizing the total number of patches at each site by the total available sites in each category. Patch frequency and mean number of patches per microtubules with at least one patch were calculated by manually counting patches on microtubules.
The analysis of tubulin fluorescence intensity at lattice patches was completed using a custom MATLAB script in which the average red fluorescence intensity was calculated over the entire microtubule by manual clicking at each end of the microtubule, and then the average red fluorescence intensity under a patch was calculated by manual clicking at the ends of an observed lattice patch. The ratio of red tubulin fluorescence at a lattice patch relative to the average red fluorescence along the length of the microtubule was then calculated according to:
Where patch_fluor is the average red tubulin fluorescence intensity under an acetylation patch, and MT_fluor is the average red fluorescence intensity along the entire length of the microtubule. If this ratio was < 1 for a given microtubule, then the patch was classified as being in a "dim" spot on the microtubule. In contrast, if this ratio was ≥ 1, then the patch was classified as being in a "bright" spot on the microtubule.
Western Blot Acetylation Assay
Acetylation Reaction Mixture
Tubulin dimers, GMPCPP microtubules, or Calcium treated GMPCPP microtubules were mixed with Acetyl CoA (2 mM final concentration), unlabeled αTAT1 (2.5 μM final concentration), and BRB80 for 90 minutes.
Reactions were kept at 37 ˚C. Aliquots were taken from reaction mixture at 0, 10, 20, 40, 60, and 90 minutes and stored at -20˚C.
Shearing Acetylation Assay
GMPCPP microtubules were mixed with Acetyl CoA (2 mM final concentration), unlabeled αTAT1 (2.5 μM final concentration), and BRB80 for 60 minutes. At 60 minutes the mixture was split into two separate mixtures. One mixture was sheared using a small diameter needle while the other mixture was not. After 120 minutes the sheared mixture was sheared a second time while the other mixture was not. Reactions were kept at 37 ˚C. Aliquots were taken from the unsheared mixture at 0, 60, 120, and180 minutes and from the sheared mixture at 120 and 180 minutes and stored at -80 ˚C for western blotting.
Cell Lysate and Known αTAT1 concentration Mixtures
Human RPE cells were grown using standard culturing conditions (in DMEM, 10% PBS, 1% penStrep), and lysed in 5X non-reducing buffer with BME by boiling for 5 minutes. Cell lysates (1, 5, and 10μl) were loaded alongside known concentrations of purified αTAT1 (3, 37.5, and 665 ng/μl).
Western Blots
The reaction mixture aliquots were analyzed for their protein concentrations using a Nanodrop ND-1000 Spectrophotometer. Aliquots were diluted in BRB80 and PAGE buffer. The samples were resolved in 10% polyacrylamide gels and then transferred to PVDF membranes. Membranes were then blocked in 3% BSA in Tris-buffered saline with 0.15% Tween and probed with primary antibodies for anti-α-tubulin (DM1A, VWR Scientific cat.#PI62204), anti-acetylated tubulin (6-11B-1, Sigma Aldrich cat. #T7451-200L), or anti-αTAT1 (C6orf134, LifeSpan Biosciences, Inc cat. #LS-C116215). The membranes were subsequently probed with a horseradish peroxidase-linked anti-mouse secondary (Santa Cruz BioTechnology cat. #SC-2005) or anti-rabbit secondary (Santa Cruz BioTechnology cat. #SC-2004) antibody and developed using chemiluminescence.
Statistical Analysis
All reported tests were calculated in R or excel and are noted in the manuscript.
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Modeling Methods
A stochastic simulation was developed to model αTAT dynamics on both the inside and the outside of the microtubule. Tables S1-S3 summarize the overall simulation behaviors and rules, including applicable variables, formulae, and parameters. Model parameters are shown in Table S4 , and are based on values experimentally gathered in this study, as well as from previously published data. Simulation parameters (e.g., such as simulation duration (t dur [s]), and time step size, (Δt step [s])) are shown in Table S5 . Finally, key modeling assumptions are summarized in Table S6 .
Essential aspects of the stochastic model include (1) Initiation of a stable microtubule "template" at the start of each microtubule simulation; (2) calculation of on and off rates on the outside of the microtubule for each αTAT1 molecule in the simulation, and then probabilistic αTAT1 molecule unbinding or rebinding at random locations on the outside of the microtubule; (3) diffusion of bound αTAT1 molecules which are on the outside of the lattice; (4) entry of αTAT1 molecules into the microtubule lumen; (5) calculation of on and off rates on the inside of the microtubule lumen for each αTAT1 molecule in the simulation, and then probabilistic αTAT1 molecule unbinding or rebinding at specified locations; (6) acetylation events inside the lumen; and (7) model-convolution image generation for αTAT1-GFP and acetylation antibody images. Following are details for each of these simulation activities:
(1) Initiation of a stable microtubule "template" at the start of each microtubule simulation
At the start of the simulation for each microtubule, a stable microtubule "template" was created, which then remained constant for the duration of each individual microtubule simulation. This was created by selecting a "tip slope" for the tip of each microtubule plus-end, according to:
Where randn is a built-in MATLAB function which produces a Gaussian random number with mean 0 and standard deviation 1, abs is a built-in MATLAB function for absolute value, and mean_slope is the mean taper angle at the microtubule plus end. The value for mean_slope was fitted to experimental data by varying the value in simulation until the average simulated microtubule fluorescence over n=300 microtubules was similar to the experimental curve ( Fig. 2A, left) .
(2) Behaviors on the external surface of the microtubule
Simulation of αTAT1 interaction with the outside of the microtubule is based on previously published data which suggests that αTAT1 binds the exterior surface of microtubules, and interacts with the C-terminal tails of tubulin (2) , and also on our own and previously published observations that αTAT1-GFP can diffuse on the external surface of microtubules ( Fig. S5 and Movie S1) (3). Thus, simulated interactions of αTAT1 with the exterior of the microtubule lattice consisted of (a) binding of αTAT1 on the exterior surface of the microtubule, (b) diffusion of αTAT1 on the exterior surface of the microtubule, and (c) unbinding of αTAT1 from the exterior surface of the microtubule. General rules for each of these activities were as follows:
(a) Binding of αTAT1 on the exterior surface of the microtubule: The on-rate of αTAT1 onto the exterior surface of the microtubule was calculated as shown in Table S1 . Then, for each individual simulated αTAT1 molecule, the probability of binding to the microtubule exterior was calculated from:
Where pr_on is the probability that a given αTAT1 molecule would bind to a microtubule in the current time step. Thus, if a uniformly distributed random number between 0 and 1 was less than the calculated value for pr_on, then the αTAT1 molecule would attach to the microtubule. All αTAT1 molecules, whether newly bound or rebinding, were attached at random locations on the microtubule, weighted by protofilament density. This is based on the assumption that there was a uniform density of αTAT1 molecules around the microtubule, and that αTAT1 could diffuse rapidly in solution outside of the microtubule lumen.
(b) Unbinding of αTAT1 from the exterior surface of the microtubule: The off-rate of αTAT1 from the exterior surface of the microtubule was calculated as shown in Table S1 , except in the case where an αTAT1 molecule was on an exposed protofilament at the microtubule tip (defined by a position on a protofilament which is longer than the shortest protofilament in the microtubule), in which case the off-rate is calculated according to Table S3 . Then, for each individual simulated αTAT1 molecule, the probability of unbinding from the microtubule exterior was calculated from:
Where pr_off is the probability that a given αTAT1 molecule would unbind from a microtubule in the current time step. Thus, if a uniformly distributed random number between 0 and 1 was less than the calculated value for pr_off, then the αTAT1 molecule would detach from the microtubule.
While a range of off-rate constants were tested to determine the impact of this value on simulation results, an order of magnitude value for the off-rate can be determined via the data in Fig. S1B , as previously described, and reproduced below (4): (5), while free concentration of αTAT1-GFP is 30 nM). Therefore, both the tubulin and the free αTAT1-GFP concentrations will remain constant and equal to the equilibrium concentrations throughout the experiment, and so: (3)). However, given that previously reported K D values for αTAT1 on microtubules are suggestive of a lattice residence time of ~1 s (K D~4 0 μM with 50 mM KCl, (3)), we tested a wide range of k off,lumen values in the simulation by varying γ, the off-rate correction for luminal αTAT1 (Fig. S5F ).
(c) Diffusion of αTAT1 on the exterior surface of the microtubule. Diffusion was experimentally observed on the surface of the microtubule, with a calculated diffusion coefficient of 0.08x10 6 nm 2 /s ( Fig. 3C and Movie S3 and (3)), consistent with previous reports of electrostatic interactions such as with the C-terminal tails of tubulin on the external surface of the microtubule (2). Thus, each bound αTAT1 molecule was allowed to diffuse on the external surface of the microtubule, with step size as shown in Table S1 and constrained by the experimentally measured diffusion coefficient. αTAT1 molecules which diffused to the end of a protofilament would remain at the tip of the protofilament, and did not continue to diffuse. Δx lattice = αTAT diffusion step size on microtubule outside lattice D lattice = αTAT diffusion coefficient on microtubule lattice Δt step = simulation time step size S u p p l e m e n t a l M a t e r i a l P a g e | 18
(3) Entry into the microtubule lumen αTAT1 molecules bound to the exterior surface of a microtubule had the opportunity to enter the microtubule lumen with rules which depended on the particular lumen entry model being tested. For the end-entry model, αTAT1 molecules which arrived at either end of a microtubule (as defined by arriving at a position which was past the length of the shortest protofilament), would enter the lumen with a probability as defined in Table S2 . For the lattice entry model, αTAT1 molecules which were bound to the lattice at any position would enter the lumen with a probability as defined in Table S2 . Parameters In the end-entry model, αTAT entry into lumen, from plus-end of microtubule ----Pr_Enter plus = probability of αTAT which is present at microtubule plus end to enter the lumen In the end-entry model, αTAT entry into lumen, from minusend of microtubule ----Pr_Enter minus = probability of αTAT which is present at microtubule minus end to enter the lumen In the lattice entry model, αTAT entry into lumen, from a defect or other opening along the length of the lattice ----Pr_Enter defect = probability of αTAT which is present at a position along the lattice to enter into the lumen
(4) Behaviors on the internal surface of the microtubule lumen
Simulation of αTAT1 interaction with the inside of the microtubule lumen (e.g., the α-tubulin acetylation site) consisted of (a) binding of αTAT1 on the interior surface of the microtubule, (b) unbinding of αTAT1 from the interior surface of the microtubule, and (c) Diffusion: given that the acetylation site is on the inside of the microtubule, we assumed that αTAT1 diffusion would exclusively occur in solution after unbinding, consistent with previous reports (3) . General rules for each of these activities were as follows: a) Binding of αTAT1 on the interior surface of the microtubule: The on-rate of αTAT1 onto the interior surface of the microtubule was calculated as shown in Table S1 . Then, for each individual simulated αTAT1 molecule, the probability of binding to the microtubule exterior was calculated from:
Where pr_on is the probability that a given αTAT1 molecule would bind to a microtubule in the current time step. Thus, if a uniformly distributed random number between 0 and 1 was less than the calculated value for pr_on, then the αTAT1 molecule would attach to the microtubule. We note that because the theoretical rebinding rate of αTAT1 molecules is very high (~1.7x10 4 s -1 ), the on rate of the αTAT1 molecules in the simulation are limited by the time step size in the simulation, which is typically 0.01 s, to reduce computational intensity. However, a corrected free αTAT1 lumen diffusion coefficient was used to compensate for the simulation time step size so that the reported travel distance between binding events for a free αTAT1 molecule was correctly reflected, as described below.
In contrast to the binding events on the external surface of the microtubule, αTAT1 molecules were not reattached at random locations on the inside of the microtubule, but rather were rebound very near to their previous location in the microtubule lumen. Here, given the high concentration of acetylation sites on the inside of the microtubule, we reasoned that free αTAT1 diffusion in solution on the inside of the microtubule would be limited by rapid rebinding of αTAT1 to nearby acetylation sites. This is due to the small volume and dense packing of tubulin subunits inside of the microtubule lumen, such that the concentration of α-tubulin Lys40 acetylation site binding sites is extremely high (~17x10 3 μM). Therefore, a typical rebinding time for a free αTAT1 molecule inside the lumen with a diffusion limited biomolecular on-rate constant k on = 1 μM -1 s -1 (6) would be (1/k on [acetylation sites]) = 6x10 -5 sec. During this time, the mean distance traveled for a free αTAT molecule prior to rebinding to an acetylation site (Δx) can then be calculated from:
Where D solution is the αTAT1 diffusion coefficient in solution (2.6x10 7 nm 2 /s), and Δt rebind is the typical rebinding time (~10 -5 ) sec. This leads to a predicted mean travel distance prior to αTAT1 rebind of ~50 nm. For simplicity and to reduce simulation computational intensity, an adjusted diffusion coefficient, D lumen , was then used to compensate for the diffusion of free αTAT1 molecules within the simulation time step size, Δt step . Thus, free αTAT1 molecules in the simulation would rebind a distance of <Δx lumen > away from their previously bound position inside of the lumen (Table S3 ). To test the sensitivity of the simulation to this parameter, the simulation predictions for a range of <Δx lumen > values was evaluated (Fig. 5G) . b) Unbinding of αTAT1 from the interior surface of the microtubule: The off-rate of αTAT1 from the interior surface of the microtubule was calculated as shown in Table S1 . Then, for each individual simulated αTAT1 molecule, the probability of unbinding from the microtubule interior acetylation site was calculated from:
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Where pr_off is the probability that a given αTAT1 molecule would unbind from an acetylation site in the current time step. Thus, if a uniformly distributed random number between 0 and 1 was less than the calculated value for pr_off, then the αTAT1 molecule would detach from the acetylation site. To test the sensitivity of the simulation to this parameter, the simulation predictions for a range of k off,lumen values was evaluated (Fig. 5G ). Δx lumen = free αTAT diffusion step size inside of microtubule lumen D lumen = free αTAT diffusion coefficient inside of microtubule lumen Δt step = simulation time step size αTAT detachment from acetylation site inside the microtubule lumen k off,lumen = γ(k off,lattice ) k off,lumen = αTAT off-rate from inside of the microtubule lumen γ = correction factor for off-rate of αTAT from exposed acetylation site relative to the external surface of microtubules
(5) Acetylation events for αTAT molecules inside the lumen
For simplicity, every acetylation site on the inside of the microtubule lumen was assumed to be nonacetylated at the start of the simulation. Then, every unacetylated site that was visited by an αTAT1 molecule during the simulation was assumed to be acetylated according to the probability of acetylation (pr ac ), and was flagged as such during the simulation. For all main text simulations, the probability of acetylation per visit (pr ac ) was 100%, and so every visit resulted in an acetylation event. However, varying this parameter value did not change acetylation patch lengths, which primarily depended on the mobility of αTAT1 within the lumen (Fig. S3D ). In addition, for simplicity it was assumed that the affinity (on and off rates) of αTAT1 was identical whether or not a tubulin subunit was acetylated.
(6) Model-convolution image creation
To visualize the localization of αTAT1-GFP and, simultaneously, the fluorescent anti-acetyl antibody pattern on microtubules at the conclusion of each simulation, we performed model-convolution to generate simulated images for comparison to experiments, as previously described (7) (8) (9) . Briefly, for the localization simulations, simulated images of αTAT1-GFP were generated by convolving the microscope point spread function with simulated fluorescent markers at the position of each simulated αTAT1-GFP molecule at the completion of a run. Here, the signal and noise were matched to experimental images, and the average fluorescence distribution curves calculated as described above.
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Model Parameters and Assumption Summary
The model parameters are summarized in Table S4 , with formulae for each parameter shown in the appropriate Table S1-S3. In addition, the simulation parameters are shown in Table S5 . Finally, key modeling assumptions are summarized in Table S6 . S u p p l e m e n t a l M a t e r i a l P a g e | 23 Observed experimentally and consistent with previous studies(2) Acetylation behavior αTAT enters the microtubule lattice to acetylate the α-tubulin dimer; arrival of αTAT on an interior dimer leads to acetylation Based on previous studies (2, 3) αTAT movement inside microtubule lumen αTAT diffuses in solution, but rebinds quickly due to the high density of tubulin binding sites inside of the lumen Theoretical considerations based on density of binding sites (6, 10) 
